Kazakh capital begins inoculations against COVID-19 with China’s Sinopharm vaccine

About This Source - CGTN

This story is an English language news item from CGTN. CGTN is a Chinese state-funded broadcaster.

Recent from CGTN:

  • Why is IP protection key to China’s development?
  • Xinjiang: Where religions coexist in harmony
  • Deng Chao: Mainstream Chinese cinema finds its way to present themes of our time
  • CGTN published this video item, entitled “Kazakh capital begins inoculations against COVID-19 with China’s Sinopharm vaccine” – below is their description.

    For more:

    https://news.cgtn.com/news/2021-05-09/Kazakh-capital-begins-inoculations-against-COVID-19-107uoAysLPG/index.html

    Kazakhstan’s capital Nur-Sultan has begun rolling out China’s Sinopharm COVID-19 vaccine to protect citizens against the coronavirus.

    CGTN YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Dan Wootton: Those that know continuous lockdowns are wrong have a duty to speak up
  • U.K.’s Boris Johnson Announces Delay In Lifting Covid Restrictions
  • Victoria stalls Pfizer vaccine amid supply concerns | Coronavirus | 9 News Australia
  • UK’s Johnson delays full lifting of virus restrictions, citing Delta variant risk
  • Biden Urges Holdouts to Get Vaccinated as U.S. Nears 600,000 Covid Deaths
  • In This Story: Sinopharm

    China National Pharmaceutical Group Corp. known as Sinopharm is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine. Shanghai Shyndec Pharmaceutical and Beijing Tiantan Biological Products.

    2 Recent Items: Sinopharm

  • China approves Sinopharm and Sinovac jabs for emergency use for children aged 3 to 17
  • WHO-approved China-made vaccines: Impact on global COVID-19 response
  • Leave a Comment